Juan F. Masa

TL;DR: In patients with OSA without daytime sleepiness, the prescription of CPAP compared with usual care did not result in a statistically significant reduction in the incidence of hypertension or cardiovascular events, and the study may have had limited power to detect a significant difference.

TL;DR: Among patients with OSA and resistant hypertension, CPAP treatment for 12 weeks compared with control resulted in a decrease in 24-hour mean and diastolic blood pressure and an improvement in the nocturnal blood pressure pattern.

TL;DR: In patients with an apnea-hypopnea index of 30 or greater and no subjective daytime sleepiness, continuous positive airway pressure did not modify quality of life, objective sleepiness or vigilance as discussed by the authors.

TL;DR: The available evidence supports the notion that CPAP is an effective symptomatic treatment for patients with the sleep apneahypopnea syndrome, and a multicenter randomized, placebo-controlled, parallel-group study was designed to evaluate the short-term effects of CPAP on quality of life, objective sleepiness, cognitive function, and arterial blood pressure in nonsleepy patients with a pathologic apnehypopna index.